Table 1.
Descriptive characteristics of persons with diagnosed HIV who are taking antiretroviral therapy—United States, 2015–2017. (N=11914)
| Characteristics | na | Col % (95% CI)b |
|---|---|---|
| Total | 11914 | |
| Age (years) | ||
| 18–29 | 989 | 9.0 (8.2–9.8) |
| 30–39 | 1947 | 16.6 (15.7–17.4) |
| 40–49 | 2894 | 24.8 (23.8–25.8) |
| >=50 | 6084 | 49.7 (48.2–51.1) |
| Current gender | ||
| Male | 8681 | 74.7 (73.2–76.3) |
| Female | 3049 | 23.8 (22.2–25.3) |
| Transgender | 169 | 1.5 (1.2–1.8) |
| Sexual orientation (selfreported) | ||
| Homosexual/gay | 4974 | 41.9 (39.7–44.2) |
| Heterosexual/straight | 5594 | 46.5 (44.2–48.8) |
| Bisexual | 987 | 8.4 (7.7–9.0) |
| Others | 359 | 3.2 (2.7–3.6) |
| Race and ethnicity | ||
| White (non-Hispanic) | 3537 | 29.6 (26.1–33.1) |
| Black (non-Hispanic) | 4983 | 41.1 (35.6–46.5) |
| Hispanic or Latino | 2594 | 22.4 (18.0–26.8) |
| Other/Multiracialc | 800 | 6.9 (6.0–7.9) |
| Healthcare insurance | ||
| No (including Ryan White only) | 1025 | 10.2 (8.4–12.0) |
| Yes | 10795 | 89.8 (88.0–91.6) |
| Healthcare coverage type | ||
| Any Private Insurance | 4113 | 35.4 (33.6–37.2) |
| Public Insurance Only | 6623 | 54.3 (52.1–56.5) |
| Ryan White Coverage Only/Uninsured | 1025 | 10.3 (8.5–12.1) |
| Poverty level | ||
| Above poverty level | 6198 | 56.6 (54.1–59.2) |
| At or below poverty level | 4902 | 43.4 (40.8–45.9) |
| Education | ||
| <High school | 2136 | 17.9 (16.6–19.1) |
| High school diploma or equivalent | 3061 | 25.7 (24.6–26.9) |
| >High school | 6664 | 56.4 (54.6–58.2) |
| Homeless at any time (past 12 months) | ||
| No | 10811 | 91.3 (90.6–92.0) |
| Yes | 1061 | 8.7 (8.0–9.4) |
| Depression | ||
| No depression | 9297 | 78.4 (77.2–79.6) |
| Any depression | 2459 | 21.6 (20.4–22.8) |
| HIV Transmission Category | ||
| MSM | 5966 | 50.9 (48.8–53.0) |
| IDU | 1260 | 9.5 (8.6–10.5) |
| MSM-IDU | 735 | 5.8 (5.1–6.5) |
| Heterosexual contact | 2654 | 21.0 (19.3–22.7) |
| Other (including NIR/NRR) | 1283 | 12.7 (10.8–14.7) |
| Cigarette smoking | ||
| No | 7800 | 65.1 (63.8–66.4) |
| Yes | 4021 | 34.9 (33.6–36.2) |
| Binge drinking (during past 30 days) | ||
| No | 9924 | 84.4 (83.3–85.5) |
| Yes | 1839 | 15.6 (14.5–16.7) |
| Noninjection drug use | ||
| No | 8230 | 70.2 (68.8–71.6) |
| Yes | 3569 | 29.8 (28.4–31.2) |
| Injection drug use | ||
| No | 11475 | 97.4 (96.8–97.9) |
| Yes | 340 | 2.6 (2.1–3.2) |
| Surveillance year | ||
| 2015 | 3654 | 32.8 (30.3–35.3) |
| 2016 | 4038 | 33.2 (30.9–35.6) |
| 2017 | 4222 | 34.0 (31.3–36.6) |
HIV, human immunodeficiency virus; CI, confidence interval; ART, antiretroviral therapy
a
Numbers are unweighted
b
Percentages and corresponding CIs are weighted percentages
c
Includes American Indian/Alaska Native, Asian, Native Hawaiian/Other Pacific Islander, or multiple races